Pfizer Launches ‘PfizerForAll’™
Pfizer’s passionate and dogged pursuit of profits reminds me of a funny quote I once read about a New York City playboy at the end of the 19th century
He pursued pleasure so hard that he overtook it.
Whoever wrote this— and I think it may have been Ambrose Bierce—appears to have borrowed the phase from Soren Kierkegaard, who remarked:
Most men pursue pleasure with such breathless haste that they hurry past it.
Over time it has become steadily harder to develop safe and effective molecules for treating diseases that are common enough to warrant the massive investment.
As the opportunities for developing legitimate drugs have shrunk, Pfizer has chased profits through fraudulent schemes.
In 2009, the company agreed to pay $2.3 billion, the largest health care fraud settlement in the history of the Department of Justice, to resolve criminal and civil liability arising from the illegal promotion of certain pharmaceutical products.
Since then, the company has discovered that the most profitable substances are not pharmaceutical products, but vaccines for which the company bears no product liability and for which it can easily persuade the governments of the world to foot the bill.
Pfizer’s latest scheme is called PfizerForAll™—which appears to be a play on the phrase “With liberty and justice for all.”
As the first paragraph of the company’s recent press release describes the new program:
Pfizer Inc. (NYSE: PFE) today introduced PfizerForAll, a user-friendly digital platform designed to make access to healthcare and managing health and wellness more seamless for people across the U.S.
The new, end-to-end experience will support the millions of Americans affected annually by common illnesses like migraine, COVID-19 or flu, and those seeking to protect themselves with adult vaccinations.
By bringing together critical resources and services into a single destination, PfizerForAll helps individuals and their families cut down on the time and steps needed to take important health actions like getting care, filling prescriptions, and finding potential savings on Pfizer medicines.
And so, Pfizer appears to be moving beyond drug development to become a “healthcare provider” in its own right.
See more here substack.com
Header image: World Trademark Review
Please Donate Below To Support Our Ongoing Work To Defend The Scientific Method
PRINCIPIA SCIENTIFIC INTERNATIONAL, legally registered in the UK as a company 
incorporated for charitable purposes. Head Office: 27 Old Gloucester Street, London WC1N 3AX.
Trackback from your site.
VOWG
| #
I wonder how many people they will kill before someone puts a stop to them?
Reply
Tom
| #
I am a fizer denier and therefore am launching NeverFizer.
Reply
Saeed Qureshi
| #
@ “ … designed to make access to healthcare and managing health and wellness more seamless for people across the U.S.”
There is no need to be so fancy or digitalization for medicine delivery. All that needs to be done is that when medication is considered and approved as safe and effective, it should be placed on shelves along with other safe and effective products. That is all.
https://bioanalyticx.com/how-about-this/
Reply